×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SYRE – spyre therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SYRE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/16
10:40 am
syre
Spyre Therapeutics (NASDAQ:SYRE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $70.00 price target on the stock.
Low
Report
Spyre Therapeutics (NASDAQ:SYRE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $70.00 price target on the stock.
1/15
12:06 pm
syre
Wall Street Bullish on Spyre Therapeutics, Inc. (SYRE) with Strong Buy Rating [Yahoo! Finance]
Low
Report
Wall Street Bullish on Spyre Therapeutics, Inc. (SYRE) with Strong Buy Rating [Yahoo! Finance]
1/12
08:27 am
syre
Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2 [Yahoo! Finance]
Medium
Report
Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2 [Yahoo! Finance]
1/12
08:00 am
syre
Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2
Medium
Report
Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2
1/11
10:02 am
syre
Spyre Therapeutics' CEO Sells 15,000 Shares [Yahoo! Finance]
Medium
Report
Spyre Therapeutics' CEO Sells 15,000 Shares [Yahoo! Finance]
1/8
04:05 pm
syre
Spyre Therapeutics Announces Grants of Inducement Awards
Low
Report
Spyre Therapeutics Announces Grants of Inducement Awards
12/19
05:58 am
syre
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Low
Report
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
12/19
05:58 am
syre
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Low
Report
Spyre Therapeutics (NASDAQ:SYRE) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/13
09:28 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Jan 09 Filed by: Burrows Scott L
Medium
Report
Form 4 Spyre Therapeutics, Inc. For: Jan 09 Filed by: Burrows Scott L
1/13
09:27 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Jan 09 Filed by: Sloan Sheldon
Medium
Report
Form 4 Spyre Therapeutics, Inc. For: Jan 09 Filed by: Sloan Sheldon
1/13
09:27 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Jan 09 Filed by: Turtle Cameron
Medium
Report
Form 4 Spyre Therapeutics, Inc. For: Jan 09 Filed by: Turtle Cameron
1/13
09:26 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Jan 09 Filed by: King-Jones Heidy
Medium
Report
Form 4 Spyre Therapeutics, Inc. For: Jan 09 Filed by: King-Jones Heidy
1/12
09:00 am
syre
Form 8-K Spyre Therapeutics, Inc. For: Jan 12
Medium
Report
Form 8-K Spyre Therapeutics, Inc. For: Jan 12
1/6
09:37 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Jan 02 Filed by: Turtle Cameron
Low
Report
Form 4 Spyre Therapeutics, Inc. For: Jan 02 Filed by: Turtle Cameron
12/3
09:52 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Dec 01 Filed by: Turtle Cameron
Medium
Report
Form 4 Spyre Therapeutics, Inc. For: Dec 01 Filed by: Turtle Cameron
11/5
09:15 pm
syre
Form 4 Spyre Therapeutics, Inc. For: Nov 03 Filed by: Turtle Cameron
Low
Report
Form 4 Spyre Therapeutics, Inc. For: Nov 03 Filed by: Turtle Cameron
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: